Back to directory

Cellebrite DI Ltd.

NASDAQ: CLBT
11.33
as of 2026-09-11
Business overview

Cellebrite DI Ltd. is a global leader in digital intelligence solutions for law enforcement, military, and intelligence agencies. The company specializes in advanced forensics, data analysis, and investigative tools designed to extract and decrypt digital evidence from mobile devices and cloud platforms.

Valuation
Loading valuation…
View open tenders in C4ISR & battle management

Update log

DateNewsImpact
9/5/2026
Timing score drop driven by recent high-level insider selling
AI review
The decline in the timing score from 64 to 52 is primarily attributed to a series of insider sales by key executives and advisors, including the Chief Revenue Officer and Chief Marketing Officer, between August 21 and August 25. While operational developments like the C-TEK product launch and new security certifications in Australia and the U.S. remain positive, the concentration of selling activity weighed heavily on the analyst revisions and timing components of the model. These sales create a short-term overhang that offsets the positive momentum generated by the firm's recent technological advancements.
9/4/2026Yahoo Finance
9/2/2026Yahoo Finance
9/2/2026Cellebrite's subsidiary, Cellebrite Federal Solutions, Inc. (CFSI), achieved the advanced CMMC Level 2 cybersecurity certification for federal operations.
9/1/2026Yahoo Finance
8/26/2026Cellebrite launched the Portable Tactical Extraction Kit (C-TEK), a new digital forensic tool designed to help deployed military and law enforcement teams quickly extract and analyze data from mobile devices, drones, and storage media.
8/26/2026Cellebrite has introduced the Portable Tactical Extraction Kit (C-TEK) to support armed forces with field-based digital forensics capabilities for processing mobile phones, SIM cards, and drones.
8/25/2026S - Sale transaction of -25,299 shares at $11.29
8/24/2026S - Sale transaction of -4,323 shares at $11.36
8/21/2026S - Sale transaction of -2,198 shares at $11.24
8/21/2026S - Sale transaction of -12,562 shares at $11.24
8/21/2026Yahoo Finance
8/20/2026Yahoo Finance
8/18/2026Yahoo Finance
8/14/2026Yahoo Finance
8/14/2026Yahoo Finance
8/14/2026Yahoo Finance
8/14/2026Cellebrite DI Ltd. — quarterly earnings release — Cellebrite DI Ltd. released its second-quarter 2026 financial results on August 13, 2026, reporting $131 million in revenue and announcing that Shiven Ramji had succeeded Thomas E. Hogan as CEO. The company also lowered its full-year 2026 ARR and revenue outlook while raising its adjusted EBITDA target.
8/13/2026Yahoo Finance
8/13/2026Yahoo Finance
8/13/2026Yahoo Finance
8/13/2026Yahoo Finance
8/12/2026S - Sale transaction of -411 shares at $16.07
8/12/2026S - Sale transaction of -139,713 shares at $15.39
8/12/2026S - Sale transaction of -230 shares at $16.07
8/3/2026
Rating revision: Rating 3 → Rating 2
AI review
The company has demonstrated strong product innovation through the launch of its Genesis AI platform and expansion into drone intelligence, which strengthens its competitive moat. While executive selling is noted, these transactions appear largely related to RSU vesting and tax obligations rather than a lack of confidence in the business. Given the positive analyst coverage and expanding addressable market, an improvement in the rating is warranted.
7/27/2026THIS ORDER PROVIDES COMPUTER FORENSIC ANALYST TRAINING FOR HOMELAND SECURITY AGENTS TO USE IN CRIMINAL INVESTIGATIONS.
7/21/2026Cellebrite DI Ltd. announced it will report its second-quarter 2026 financial results on August 13, 2026.
7/14/2026Cellebrite CEO Thomas Hogan sold 103,000 shares, primarily to cover tax obligations related to the vesting of RSUs.
7/8/2026S - Sale transaction of -41,734 shares at $16.38
7/8/2026Cellebrite expanded its partnership with SkySafe to integrate drone detection and airspace intelligence into its digital forensics and investigative platform.
7/2/2026S - Sale transaction of -103,188 shares at $15.76
6/20/2026DA Davidson initiated coverage of Cellebrite DI Ltd. with a positive outlook, citing growth potential in its addressable market.
6/19/2026A bullish investment thesis on Cellebrite DI Ltd. highlights the company's valuation and market position.
6/10/2026Cellebrite announced the general availability of 'Genesis,' a new investigative tool that uses agentic AI to help investigators analyze digital evidence.
6/5/2026Cellebrite DI Ltd. announced its participation in two upcoming investor events scheduled for June 10, 2026.
5/21/2026S - Sale transaction of -5,673 shares at $13.13
5/18/2026S - Sale transaction of -12,658 shares at $12.77
5/12/2026S - Sale transaction of -228 shares at $13.01